GERNGROSS TILLMAN U has a total of 17 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are PFENEX INC, GLYCOFI INC and ALGENICS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 15 | |
#2 | Canada | 1 | |
#3 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Agriculture | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Fermentation | |
#4 | Therapeutic chemical compounds | |
#5 | Animal care | |
#6 | Enzymes | |
#7 | Combinatorial chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Gerngross Tillman U | 17 |
#2 | Wildt Stefan | 13 |
#3 | Li Huijuan | 8 |
#4 | Choi Byung-Kwon | 5 |
#5 | Bobrowicz Piotr | 5 |
#6 | Nett Juergen Hermann | 4 |
#7 | Davidson Robert C | 4 |
#8 | Hamilton Stephen R | 4 |
#9 | Anderson Errik | 1 |
#10 | Hamilton Stephen | 1 |
Publication | Filing date | Title |
---|---|---|
US2006034830A1 | Immunoglobulins comprising predominantly a GalGlcNAcMan5GLcNAc2 glycoform | |
US2006034829A1 | Immunoglobulins comprising predominantly a MAN3GLCNAC2 glycoform | |
US2006034828A1 | Immunoglobulins comprising predominantly a GlcNAcMAN5GLCNAC2 glycoform | |
US2006024304A1 | Immunoglobulins comprising predominantly a Man5GlcNAc2 glycoform | |
US2006024292A1 | Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoform | |
US2006029604A1 | Immunoglobulins comprising predominantly a GlcNAc2Man3GlcNAc2 glycoform |